CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Iopromide

碘普罗胺 杂质对照品Iopromide Impurities

EP33 个杂质条目33 impurity entries

本页汇总 碘普罗胺 的 33 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 33 impurity reference standards of Iopromide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 碘普罗胺(Iopromide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesElucidation of phototransformation reactions of the X-ray contrast medium iopromide under simulated solar radiation using UPLC-ESI-QqTOF-MS
    Journal of mass spectrometry : JMS · 2009 · Pérez S et al.  ·  PMID 19565538  ·  DOI
  2. 分析方法Analytical MethodsDevelopment and Application of Analytical Method for Simultaneous Quantification of Iopromide and Iodixanol in Human Plasma
    International journal of analytical chemistry · 2025 · Ye L et al.  ·  PMID 41477355  ·  DOI

碘普罗胺 —— 原料药与杂质对照品Iopromide — drug substance & impurities

共 34 个条目(含原料药本体)34 items incl. the drug substance
Iopromide structure
EP原料药 APIAPI
碘普罗胺Iopromide
Iopromide
CAS No.73334-07-3
Chemical FormulaC18H24I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 1 (Iopromide EP Impurity A) structure
EPA
碘普罗胺杂质1(碘普罗胺EP杂质A)Iopromide Impurity 1 (Iopromide EP Impurity A)
Iopromide Impurity 1 (Iopromide EP Impurity A)
CAS No.154361-51-0
Chemical FormulaC15H20I3N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 2 (Iopromide EP Impurity B) structure
EPB
碘普罗胺杂质2(碘普罗胺EP杂质B)Iopromide Impurity 2 (Iopromide EP Impurity B)
Iopromide Impurity 2 (Iopromide EP Impurity B)
CAS No.76350-28-2
Chemical FormulaC17H22I3N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 3 (Iopromide EP Impurity C) structure
EPC
碘普罗胺杂质3(碘普罗胺EP杂质C)Iopromide Impurity 3 (Iopromide EP Impurity C)
Iopromide Impurity 3 (Iopromide EP Impurity C)
CAS No.154361-52-1
Chemical FormulaC17H22I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 4 (Iopromide EP Impurity D) structure
EPD
碘普罗胺杂质4(碘普罗胺EP杂质D)Iopromide Impurity 4 (Iopromide EP Impurity D)
Iopromide Impurity 4 (Iopromide EP Impurity D)
CAS No.154361-55-4
Chemical FormulaC36H46I6N6O15
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 5 (Iopromide EP Impurity E) structure
EPE
碘普罗胺杂质5(碘普罗胺EP杂质E)Iopromide Impurity 5 (Iopromide EP Impurity E)
Iopromide Impurity 5 (Iopromide EP Impurity E)
CAS No.154397-78-1
Chemical FormulaC32H37I6N5O14
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 6 (Iopromide EP Impurity F) structure
EPF
碘普罗胺杂质6(碘普罗胺EP杂质F)Iopromide Impurity 6 (Iopromide EP Impurity F)
Iopromide Impurity 6 (Iopromide EP Impurity F)
CAS No.154361-54-3
Chemical FormulaC21H28I3N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 7 (Iopromide EP Impurity G) structure
EPG
碘普罗胺杂质7(碘普罗胺EP杂质G)Iopromide Impurity 7 (Iopromide EP Impurity G)
Iopromide Impurity 7 (Iopromide EP Impurity G)
CAS No.154361-53-2
Chemical FormulaC18H23ClI3N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 8 (Iopromide EP Impurity H) structure
EPH
碘普罗胺杂质8(碘普罗胺EP杂质H)Iopromide Impurity 8 (Iopromide EP Impurity H)
Iopromide Impurity 8 (Iopromide EP Impurity H)
CAS No.185459-57-8
Chemical FormulaC14H15I3N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 10 structure
10
碘普罗胺杂质10Iopromide Impurity 10
Iopromide Impurity 10
CAS No.219851-74-8
Chemical FormulaC16H3Cl3I6N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 14 structure
14
碘普罗胺杂质14Iopromide Impurity 14
Iopromide Impurity 14
CAS No.77697-86-0
Chemical FormulaC4H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 20 structure
20
碘普罗胺杂质20Iopromide Impurity 20
Iopromide Impurity 20
CAS No.57469-50-8
Chemical FormulaC2H3ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 21 structure
21
碘普罗胺杂质21Iopromide Impurity 21
Iopromide Impurity 21
CAS No.102356-49-0
Chemical FormulaC4H10ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 22 structure
22
碘普罗胺杂质22Iopromide Impurity 22
Iopromide Impurity 22
CAS No.83804-96-0
Chemical FormulaC5H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 32 structure
32
碘普罗胺杂质32Iopromide Impurity 32
Iopromide Impurity 32
CAS No.103254-70-2
Chemical FormulaC17H22I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 33 structure
33
碘普罗胺杂质33Iopromide Impurity 33
Iopromide Impurity 33
CAS No.127324-01-0
Chemical FormulaC8H6INO4
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 36 structure
36
碘普罗胺杂质36Iopromide Impurity 36
Iopromide Impurity 36
CAS No.2756222-52-1
Chemical FormulaC8H4ClI2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 37 structure
37
碘普罗胺杂质37Iopromide Impurity 37
Iopromide Impurity 37
CAS No.219851-75-9
Chemical FormulaC16H4Cl2I6N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 39 structure
39
碘普罗胺杂质39Iopromide Impurity 39
Iopromide Impurity 39
CAS No.2184991-45-3
Chemical FormulaC3H9ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 40 structure
40
碘普罗胺杂质40Iopromide Impurity 40
Iopromide Impurity 40
CAS No.939027-86-8
Chemical FormulaC5H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 48 structure
48
碘普罗胺杂质48Iopromide Impurity 48
Iopromide Impurity 48
CAS No.87932-06-7
Chemical FormulaC10H4Cl2I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 55 structure
55
碘普罗胺杂质55Iopromide Impurity 55
Iopromide Impurity 55
CAS No.2992672-98-5
Chemical FormulaC18H22I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 56 structure
56
碘普罗胺杂质56Iopromide Impurity 56
Iopromide Impurity 56
CAS No.2992672-97-4
Chemical FormulaC18H22I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 57 structure
57
碘普罗胺杂质57Iopromide Impurity 57
Iopromide Impurity 57
CAS No.2992673-01-3
Chemical FormulaC16H20I3N3O10S
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 58 structure
58
碘普罗胺杂质58Iopromide Impurity 58
Iopromide Impurity 58
CAS No.2992673-00-2
Chemical FormulaC16H20I3N3O10S
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 59 structure
59
碘普罗胺杂质59Iopromide Impurity 59
Iopromide Impurity 59
CAS No.1613297-04-3
Chemical FormulaC8H12O6
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 62 structure
62
碘普罗胺杂质62Iopromide Impurity 62
Iopromide Impurity 62
CAS No.130930-29-9
Chemical FormulaC3H7NO4
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 72 structure
72
碘普罗胺杂质72Iopromide Impurity 72
Iopromide Impurity 72
CAS No.20546-32-1
Chemical FormulaC3H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 76 structure
76
碘普罗胺杂质76Iopromide Impurity 76
Iopromide Impurity 76
CAS No.40137-22-2
Chemical FormulaC4H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 77 (N-Nitroso Iopromide Impurity 76) structure
77
碘普罗胺杂质77 (N-亚硝基碘普罗胺杂质76)Iopromide Impurity 77 (N-Nitroso Iopromide Impurity 76)
Iopromide Impurity 77 (N-Nitroso Iopromide Impurity 76)
CAS No.86451-37-8
Chemical FormulaC4H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 82 structure
82
碘普罗胺杂质82Iopromide Impurity 82
Iopromide Impurity 82
CAS No.13052-19-2
Chemical FormulaC2H5NO2
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 86 structure
86
碘普罗胺杂质86Iopromide Impurity 86
Iopromide Impurity 86
CAS No.76350-04-4
Chemical FormulaC14H14ClI3N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 90 structure
90
碘普罗胺杂质90Iopromide Impurity 90
Iopromide Impurity 90
CAS No.745720-71-2
Chemical FormulaC4H10ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Iopromide Impurity 92 structure
92
碘普罗胺杂质92Iopromide Impurity 92
Iopromide Impurity 92
CAS No.81462-55-7
Chemical FormulaC4H8Cl3N
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

碘普罗胺 —— 研究文献与合成路线Iopromide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 碘普罗胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Iopromide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Degradation of iopromide by combined UV irradiation and peroxydisulfate
    Chan TW, Graham NJ, Chu W · Journal of hazardous materials · 2010 · 被引 32cited 32
  2. Degradation of iopromide during the UV-LED/chlorine reaction: Effect of wavelength, radical contribution, transformation products, and toxicity
    Cha Y, Kim TK, Lee J, et al. · Journal of hazardous materials · 2022 · 被引 11cited 11
  3. Removal of iopromide and degradation characteristics in electron beam irradiation process
    Kwon M, Yoon Y, Cho E, et al. · Journal of hazardous materials · 2012 · 被引 13cited 13
  4. Isolation and identification of an iopromide-degrading strain and its application in an A2/O system
    Liu Y, Hu J, Xu B, et al. · Bioresource technology · 2013 · 被引 5cited 5
  5. [Study on the iopromide-degrading characteristics of strain Pseudomonas sp. I-24 via co-metabolism]
    Xu BJ, Gao P, Xue G, et al. · Huan jing ke xue= Huanjing kexue · 2014

合成与制备工艺专利Synthesis & process patents

  1. NOVEL PROCESS FOR PREPARATION OF IOPROMIDE
    HWANG KOOK SANG, CHUNG SOON MIN, KIM CHANG KI, KIM BOK TAE, et al. · 公开号 WO2009134030WO2009134030 · 2009
  2. NOVEL PROCESS FOR PREPARATION OF IOPROMIDE
    HWANG KOOK SANG, CHUNG SOON MIN, KIM CHANG KI, KIM BOK TAE, et al. · 公开号 US2011034730US2011034730 · 2011
  3. NOVEL PROCESS FOR PREPARATION OF IOPROMIDE
    HWANG KOOK SANG, CHUNG SOON MIN, KIM CHANG KI, KIM BOK TAE, et al. · 公开号 EP2271615EP2271615 · 2011
  4. NOVEL PROCESS FOR PREPARATION OF IOPROMIDE
    HWANG KOOK SANG, CHUNG SOON MIN, KIM CHANG KI, KIM BOK TAE, et al. · 公开号 KR20090114729KR20090114729 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

碘普罗胺 杂质谱研究要点Iopromide — impurity profiling notes

下面这些是拿到 碘普罗胺 的 34 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 34 impurity entries for Iopromide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances